Conference & Events
Event Details
Viral Safety for Biopharmaceuticals used in Clinical Trials - The Impact of the New EMEA Guideline
This Viral Safety training/webinar will discuss the criteria and scope of viral safety studies needed prior and during clinical development as stated in new EMEA guidance document.
Date: 17 November 2009 10:00 - 11:00
Event Subject(s):
Biosciences
Education
Forensic Science
Organic
Venue
Online Webinar
United States of America
Useful link:
http://www.complianceonline.com/ecommerce/control/train...
Organiser Information
Organiser(s): ComplianceOnline
Contact for Event Information
Name : Mr Admin
United States of America
Tel:
+ 650-620-3937
Fax:
+ 650-963-2556
Email:
admin@complianceonline.com
Contact Useful link:
http://www.complianceonline.com
Additional Information
Speaker Information:
Kathryn Martin Remington, Ph.D. is the Senior Manager of Virology at Catalent Pharma Solutions, in Research Triangle Park, North Carolina, a full-service solution provider to the pharmaceutical industry. She holds M.S. and Ph.D. degrees in Microbiology and has over 20 years of experience in virology. Before coming to industry, she worked in research studying drug resistant AIDS viruses. She was previously the Section Head of Viral Validation for Bayer HealthCare. Kathryn has been involved in the viral safety of biologics for over 12 years and is the author of number scientific publications on viral safety. She is a frequent speaker at conferences and workshops.
Useful link:
http://www.complianceonline.com/ecommerce/control/train...
